The latest guidance does not apply to a requirement for transparency in pharmacy benefits and drug prices, which is scheduled to go into effect at the end of the year. (Photo: Shutterstock)
Hospitals and health systems did their best to delay the first iteration of the federal price transparency rule requiring them to disclose prices, to no avail. Health insurers, however, are having a little more luck. Last week, the Centers for Medicare & Medicaid Services announced a six-month delay in enforcement of several of the insurer price transparency law's key provisions, which is scheduled to take effect on January 1, 2022.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Emily Payne
Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.
